The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals

被引：0
|
作者：
Sigrid Haeggström
Magnus Ingelman-Sundberg
Svante Pääbo
Hugo Zeberg
机构：
[1] Karolinska Institutet,Department of Neuroscience
[2] Karolinska Institutet,Department of Physiology and Pharmacology
[3] Max Planck Institute for Evolutionary Anthropology,Department of Evolutionary Genetics
[4] Okinawa Institute of Science and Technology,Human Evolutionary Genomics Unit
来源：
The Pharmacogenomics Journal | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Genetic variation in genes encoding cytochrome P450 enzymes influences the metabolism of drugs and endogenous compounds. The locus containing the cytochrome genes CYP2C8 and CYP2C9 on chromosome 10 exhibits linkage disequilibrium between the CYP2C8*3 and CYP2C9*2 alleles, forming a haplotype of ~300 kilobases. This haplotype is associated with altered metabolism of several drugs, most notably reduced metabolism of warfarin and phenytoin, leading to toxicity at otherwise therapeutic doses. Here we show that this haplotype is inherited from Neandertals.
引用
收藏
页码：247 / 249
页数：2
相关论文
共 50 条
  • [1] The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
    Haeggstrom, Sigrid
    Ingelman-Sundberg, Magnus
    Paabo, Svante
    Zeberg, Hugo
    PHARMACOGENOMICS JOURNAL, 2022, 22 (04): : 247 - 249
  • [2] Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms
    Yasar, U
    Lundgren, S
    Eliasson, E
    Bennet, A
    Wiman, B
    de Faire, U
    Rane, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (01) : 25 - 28
  • [3] Global variation in CYP2C8–CYP2C9 functional haplotypes
    William C Speed
    Soonmo Peter Kang
    David P Tuck
    Lyndsay N Harris
    Kenneth K Kidd
    The Pharmacogenomics Journal, 2009, 9 : 283 - 290
  • [4] Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population
    Kudzi, William
    Dodoo, Alexander N. O.
    Mills, Jeremy J.
    BMC MEDICAL GENETICS, 2009, 10
  • [5] EFFECT OF CYP2C9 AND CYP2C8 POLYMORPHISMS ON PHARMACOKINETICS OF IBUPROFEN ENANTIOMERS
    Abad-Santos, F.
    Ochoa, D.
    Prieto-Perez, R.
    Roman, M.
    Talegon, M.
    Rivas, A.
    Cabaleiro, T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 23 - 23
  • [6] Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively
    Wen, X
    Wang, JS
    Backman, JT
    Laitila, J
    Neuvonen, PJ
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (06) : 631 - 635
  • [7] CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
    Johansson, Maria
    Strahm, Emmanuel
    Rane, Anders
    Ekstrom, Lena
    FRONTIERS IN GENETICS, 2014, 5
  • [8] Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues
    DeLozier, Tracy C.
    Kissling, Grace E.
    Coulter, Sherry J.
    Dai, Diana
    Foley, Julie F.
    Bradbury, J. Alyce
    Murphy, Elizabeth
    Steenbergen, Charles
    Zeldin, Darryl C.
    Goldstein, Joyce A.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (04) : 682 - 688
  • [9] The role of CYP2C8 and CYP2C9 genotypes in acute myocardial infarction
    Yasar, Ü
    Bennet, A
    Eliasson, E
    Lundgren, S
    Wiman, B
    de Faire, U
    Rane, A
    DRUG METABOLISM REVIEWS, 2003, 35 : 132 - 132
  • [10] Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population
    Halling, J
    Petersen, M
    Damkier, P
    Nielsen, F
    Grandjean, P
    Weihe, P
    Lundgren, S
    Lundblad, M
    Brosen, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (07) : 491 - 497
12345